News Articles on 'Clinical Pharmacology & Toxicology'
Which medications are most toxic to the liver?
A new study published in the British Journal of Clinical Pharmacology ¬provides insights on how common hospitalized patients develop liver injury from taking different medications. When ...
Published: 05 May 2021
Neuroscience Research Day Features 48 Presentations
Forty-eight oral and poster presentations were showcased at the 14th annual Buffalo Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).
Source: Medicine Buffalo
Published: 17 May 2021
Masters and Ph.D. Admissions at NIPER; Apply by May 8
Those with B.Pharm; B.A.M.S; B.V.Sc; M.B.B.S; BDS, and those with B.Tech/B.E in specified branches, M.Sc in specified areas can apply for the different Master's programs. The centers where courses are available and eligibility for admission to each course at centers is given in the Master's Brochure available at For admission to Masters Programs,
Published: 08 May 2021
Gain Therapeutics, Inc. Reports First Quarter 2021 Financial Results
Completed successful initial public offering and raised $46 million in gross proceeds --- Appointed four new independent board of directors to strengthen leadership team ---Signed a multi-target collaboration agreement with Zentalis Pharmaceuticals (Nasdaq: ZNTL) to discover new product candidates for the treatment of cancer---Presented positive pre-clinical lysosomal storage target data at annual WorldSymposium™---Expect to complete proof of concept animal studies and begin IND-enabling trials in the second half of 2021 BETHESDA,
Source: Yahoo UK & Ireland
Published: 10 May 2021
Schrodinger Inc (SDGR) Q1 2021 Earnings Call Transcript
Q1 2021 Earnings Call May 11, 2021, 8:30 a.m. ET Thank you for standing by. Welcome to Schrodinger's conference call to review the company's first quarter financial results. My name is Kevin, and I'll be your operator for today's call.
Source: The Motley Fool on MSN.com
Published: 12 May 2021
Gain Therapeutics, Inc. Reports First Quarter 2021
Body> Completed successful initial public offering and raised $46 million in gross proceeds <br/> --- <br/> Appointed four new independent board of directors to strengthen leadership team <br/> ---<br
Source: Middle East North Africa Financial Network
Published: 10 May 2021
Biotechnology Company Centivax Officially Launches
Centivax Inc. is proud to announce its launch on Jan. 1, 2021, as a fully independent biotechnology company developing broad-spectrum therapeutics and a vaccines portfolio, including indications in COVID-19,
Source: Associated Press
Published: 29 Apr 2021